Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALL

Clinical trial NCT01148134 · TERMINATED

Trial details

NCT number: NCT01148134
Sponsor: University Health Network, Toronto
Status: TERMINATED
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia

Start date: 2010-06-01
Primary completion: 2012-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.